Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 5, 2012

$500K Grant for Microarray Film Dx Platform

  • Akonni Bioystems was awarded a $498,780 Phase II SBIR Grant from the national Science Foundation to further develop its Lab-on-a-Film, which has been designed as an ultra-low-cost microarray film manufactured using an automated reel-to-reel production process.

    The firm claims the Lab-on-a-Film technology has the potential to allow the production of multiplexed microarray consumables for just a few dollars. The platform hinges on Akonni’s TruArray™ gel-drop multiplex microarray technology, and is being designed to allow the production of a hands-free, end-to-end genetic testing system.

    Akonni’s TruArray technology involves attaching capture probes covalently to an ultra-high surface area polymer backbone of discrete three dimensional gel-drops rather than a two-dimensional substrate. The firm says this means the individual gel drops behave as individual nanoliter, solution-phase test tubes, which negates the potential for unpredictable and/or uncharacterized artifacts arising from probe deposition directly on a two-dimensional surface.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »